Ganga Pharmaceuticals (BOM:539680) Net Income From Continuing Operations : ₹0.95 Mil (TTM As of Mar. 2025)

View and export this data going back to 2016. Start your Free Trial

What is Ganga Pharmaceuticals Net Income From Continuing Operations?

Net Income From Continuing Operations indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. Ganga Pharmaceuticals's net income from continuing operations for the six months ended in Mar. 2025 was ₹0.28 Mil. Its net income from continuing operations for the trailing twelve months (TTM) ended in Mar. 2025 was ₹0.95 Mil.

Ganga Pharmaceuticals Net Income From Continuing Operations Historical Data

The historical data trend for Ganga Pharmaceuticals's Net Income From Continuing Operations can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ganga Pharmaceuticals Net Income From Continuing Operations Chart

Ganga Pharmaceuticals Annual Data

Trend

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Mar25

Net Income From Continuing Operations

Get a 7-Day Free Trial

0.37

0.51

0.53

0.63

0.95

Ganga Pharmaceuticals Semi-Annual Data
	Sep15	Mar16	Sep16	Mar17	Sep17	Mar18	Sep18	Mar19	Sep19	Mar20	Sep20	Mar21	Sep21	Mar22	Sep22	Mar23	Sep23	Mar24	Sep24	Mar25
Net Income From Continuing Operations	Get a 7-Day Free Trial															0.10	0.19	0.45	0.67	0.28

Ganga Pharmaceuticals Net Income From Continuing Operations Calculation

Net Income From Continuing Operations indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. It excludes extraordinary items, income from the cumulative effects of accounting changes, non-recurring items, income from tax loss carry forward, and preferred dividends.

Net Income From Continuing Operations for the trailing twelve months (TTM) ended in Mar. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was ₹0.95 Mil.

Ganga Pharmaceuticals Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Ganga Pharmaceuticals Ltd (BOM:539680) » Definitions » Net Income From Continuing Operations

Traded in Other Exchanges

N/A

Address

Dhanvantri Marg, Gangatat, Gopcharpada, Near Digi 1 Electronic Showroom, Virar (East), Palghar, MH, IND, 401305

Website

https://www.ayurvedganga.com

Ganga Pharmaceuticals Ltd is an India based producer of ayurvedic medicines. It is engaged in the business of manufacturing and trading in ayurvedic pharmaceuticals and allied products. The company is also involved in the marketing and distribution of bulk ayurvedic medicines. The firm offers ayurvedic medicines for acidity, anti-dandruff, anti-oxidants, dental care, diarrhea, iron tonic, liver disorder, weight management, kidney stone, joint pains, liver disorder and others.

Ganga Pharmaceuticals Headlines

No Headlines